NO164295B - ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. - Google Patents

ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. Download PDF

Info

Publication number
NO164295B
NO164295B NO861486A NO861486A NO164295B NO 164295 B NO164295 B NO 164295B NO 861486 A NO861486 A NO 861486A NO 861486 A NO861486 A NO 861486A NO 164295 B NO164295 B NO 164295B
Authority
NO
Norway
Prior art keywords
triazole
formula
alkyl
difluorobenzyl
compound
Prior art date
Application number
NO861486A
Other languages
Norwegian (no)
Other versions
NO861486L (en
NO164295C (en
Inventor
Rene Meier
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of NO861486L publication Critical patent/NO861486L/en
Publication of NO164295B publication Critical patent/NO164295B/en
Publication of NO164295C publication Critical patent/NO164295C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C247/00Compounds containing azido groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40Halogenated unsaturated alcohols
    • C07C33/46Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Description

Oppfinnelsen vedrører en analogifremgangsmåte til fremstil- The invention relates to an analogous method for manufacturing

ling av terapeutisk anvendbare, fluorerte l-(a-fenylalkyl)-1H-1,2,3-triazolforbindelser med formel ling of therapeutically useful, fluorinated 1-(α-phenylalkyl)-1H-1,2,3-triazole compounds of formula

hvori Ph betyr en i o-stilling med fluor og eventuelt i tillegg et ytterligere halogenatom substituert fenylrest, alk betyr Cj,-C3-alkyliden, R^ betyr hydrogen, C1-C4-alkyl, eller en usubstituert eller med C^-C4-alkanoyl eller C^-C4~alkyl substituert karbamylgruppe, og R2 betyr en usubstituert eller med Ci-C4-alkanoyl eller C^-C4-alkyl substituert karbamyl- in which Ph means an i o-position with fluorine and optionally in addition a further halogen atom substituted phenyl residue, alk means Cj,-C3-alkylidene, R^ means hydrogen, C1-C4-alkyl, or an unsubstituted or with C^-C4- alkanoyl or C 1 -C 4 -alkyl substituted carbamyl group, and R 2 means an unsubstituted or with C 1 -C 4 -alkanoyl or C 1 -C 4 -alkyl substituted carbamyl-

gruppe . group.

Som ekstra halogensubstituenter av Ph, kommer halogenatomer As additional halogen substituents of Ph, halogen atoms come

med atomnummer til og med 35, som fluor eller klor i betraktning. with atomic numbers up to and including 35, such as fluorine or chlorine in consideration.

C^-Cs-alkyliden er eksempelvis metylen, videre etyliden, 1,1-propyliden eller 2,2-propyliden (isopropyliden). The C 1 -C 5 alkylidene is, for example, methylene, further ethylidene, 1,1-propylidene or 2,2-propylidene (isopropylidene).

Ci-C4-alkyl er eksempelvis metyl eller i annen rekke etyl, Ci-C4-alkyl is, for example, methyl or, in other words, ethyl,

propyl, isopropyl, butyl, isobutyl, sekundær butyl eller tertiær butyl. propyl, isopropyl, butyl, isobutyl, secondary butyl or tertiary butyl.

Med C1-C4-alkanoyl eller C^-C4-alkyl substituert karbamyl er With C1-C4-alkanoyl or C1-C4-alkyl substituted carbamyl is

spesielt med C^-C4-alkanoyl mono- eller med C1-C4~alkyl disubstituert og betyr eksempelvis N-Ci-C4-alkanoylkarbamyl, especially with C 1 -C 4 -alkanoyl mono- or with C 1 -C 4 -alkyl disubstituted and means for example N -C 1 -C 4 -alkanoylcarbamyl,

i første rekke N-C2-C4-alkanoylkarbamyl, som acetylkarbamoyl eller N,N-di-C^-C4-alkylkarbamyl, som N,N-dimetylkarbamyl eller N,N-dietylkarbamyl. primarily N-C2-C4-alkanoylcarbamyl, such as acetylcarbamoyl or N,N-di-C1-C4-alkylcarbamyl, such as N,N-dimethylcarbamyl or N,N-diethylcarbamyl.

De nye forbindelser med formel I har verdifulle farmakolo-giske egenskaper, spesielt en utpreget antikonvulsiv virkning, som lar seg vise eksempelvis på mus ved hjelp av en tydelig metrazol-antagonisme i - doseområder fra 30 til 300 mg/kg p.o., såvel på mus og rotte ved hjelp av en utpreget beskyttelsesvirkning mot elektrosjokk-utløste konvulsjoner i doseområder på ca. 1 til ca. 50, i de fleste tilfeller fra ca. 1 til ca. 25 mg/kg p.o. Sajnmenligningsforsøk utført med følgende forbindelser fremstilt ;ifølge oppfinnelsen: l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid, I; l-(o-fluorbenzyl)-lH-l,2,3-triazol-4-karboksamid, II; l-(2,6-di fluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid , III; l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4,5-dikarboksamid, IV; l-(o-fluorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid, V; l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4-karboksamid, VI; l-(2,5-di fluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid , VII; med de strukturelt nærmestliggende kjente forbindelsene l-(o-klorbenzyl)-lH-l,2,3-triazol-4-karboksamid, IX og l-(o-klorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid, X ifølge EP-A1-114 347, samt l-(o-klorbenzyl)-5-amino-lH-l,2, 3- tr i azol-4-karboksyl syr e-piperidid, XI ifølge GB-PS-1511195 ga verdiene angitt i den etterfølgende tabellen for den effektive dosen ED50 (ved 1 times forapplikasjon): The new compounds of formula I have valuable pharmacological properties, in particular a pronounced anticonvulsant effect, which can be shown, for example, in mice by means of a clear metrazole antagonism in - dose ranges from 30 to 300 mg/kg p.o., both in mice and rat by means of a pronounced protective effect against electroshock-triggered convulsions in dose ranges of approx. 1 to approx. 50, in most cases from approx. 1 to approx. 25 mg/kg p.o. Comparison experiments carried out with the following compounds prepared according to the invention: 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, I; 1-(o-Fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, II; 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, III; 1-(6-chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, IV; 1-(o-Fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, V; 1-(6-Chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4-carboxamide, VI; 1-(2,5-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, VII; with the structurally closest known compounds 1-(o-chlorobenzyl)-1H-1,2,3-triazole-4-carboxamide, IX and 1-(o-chlorobenzyl)-1H-1,2,3-triazole-4, 5-dicarboxamide, X according to EP-A1-114 347, as well as 1-(o-chlorobenzyl)-5-amino-1H-1,2,3-tr iazole-4-carboxylic acid e-piperidide, XI according to GB- PS-1511195 gave the values indicated in the following table for the effective dose ED50 (at 1 hour pre-application):

Forbindelsene (I) til (VIII) fremstilt ifølge oppfinnelsen adskiller seg følgelig fra kjente, strukturanaloge forbindelser (IX) til (XI) ifølge teknikkens stand ved en vesentlig sterkere virkning og er følgelig utmerket egnet til behandling av konvulsjoner av forskjellig genese, eksempelvis til behandling av epilepsi, og kan anvendes som antikonvulsive, eksempelvis antlepileptisk virksomme stoffer i legemidler. The compounds (I) to (VIII) produced according to the invention consequently differ from known, structurally analogous compounds (IX) to (XI) according to the state of the art by having a significantly stronger effect and are consequently excellently suitable for the treatment of convulsions of different genesis, for example for the treatment of epilepsy, and can be used as anticonvulsants, for example antiepileptically active substances in pharmaceuticals.

Oppfinnelsen vedrører i første rekke fremstillingen av forbindelser med formel I, hvori Ph betyr o-fluorfenyl eller 2,6-difluorfenyl, alk står for metylen, R^ betyr hydrogen eller usubstituert karbamyl og R2 er usubstituert karbamyl. The invention primarily relates to the preparation of compounds of formula I, in which Ph means o-fluorophenyl or 2,6-difluorophenyl, alk stands for methylene, R 1 means hydrogen or unsubstituted carbamyl and R 2 is unsubstituted carbamyl.

Oppfinnelsen vedrører fortrinnsvis fremstilling av forbindelser med formel I, hvori Ph betyr 2 ,6-difluorfenyl, alk betyr metylen, R^ betyr hydrogen, C^-^-alkyl , som metyl eller en rest Rg>°g R2 DetYr karbamyl, N-C2~C5-alkanoylkarbamyl, som acetylkarbamyl eller N,N-di-C^-C4-alkylkarbamyl, som dimetylkarbamyl. The invention preferably relates to the preparation of compounds of formula I, in which Ph means 2,6-difluorophenyl, alk means methylene, R^ means hydrogen, C^-^-alkyl, such as methyl or a residue Rg>°g R2 DetYr carbamyl, N- C2~C5-alkanoylcarbamyl, such as acetylcarbamyl or N,N-di-C^-C4-alkylcarbamyl, such as dimethylcarbamyl.

Oppfinnelsen vedrører fremfor alt fremstillingen av forbindelser med formel J, iivorl Ph betyr o-fluorfenyl, 2,5-difluorfenyl, 2,6-difluorfenyl eller 2-klor-6-fluor-fenyl, alk står for metylen og 8^ og R2 betyr begge karbamyl, videre forbindelser av formel I hvori Ph betyr 2,6-difluorfenyl, alk betyr metylen, Ri betyr hydrogen eller karbamyl og R2 betyr karbamyl. The invention relates above all to the preparation of compounds of formula J, where Ph means o-fluorophenyl, 2,5-difluorophenyl, 2,6-difluorophenyl or 2-chloro-6-fluoro-phenyl, alk stands for methylene and 8^ and R2 means both carbamyl, further compounds of formula I in which Ph means 2,6-difluorophenyl, alk means methylene, R 1 means hydrogen or carbamyl and R 2 means carbamyl.

Fremgangsmåten til fremstilling av forbindelsen med formel I beror på i og for seg kjente metoder og er kjennetegnet ved at man The process for producing the compound of formula I is based on methods known per se and is characterized by the fact that

a) på kjent måte amiderer en forbindelse av formelen a) amidates a compound of the formula in a known manner

hvori R'i betyr hydrogen, C^-C^alkyl eller en gruppe av wherein R'i means hydrogen, C 1 -C 4 alkyl or a group of

formelen -COOR3 og R'2 betyr en gruppe -C00R3, hvorved R3 er C^-C^-alkyl , eller R'i er hydrogen eller C^-C^alkyl og R'2 er halogenkarbonyl, eller the formula -COOR3 and R'2 means a group -C00R3, whereby R3 is C^-C^-alkyl, or R'i is hydrogen or C^-C^alkyl and R'2 is halocarbonyl, or

b) omsetter en forbindelse av formelen b) reacts a compound of the formula

med en forbindelse av formelen with a compound of the formula

som eventuelt kan foreligge-i tautomer form, which may possibly exist-in tautomeric form,

hvori Ri betyr Ci-C4-alkyl, Yj betyr hydroksy og Y2 .betyr hydrogen eller Rj betyr hydrogen, karbamyl eller Ci-C4~alkyl in which Ri means C1-C4-alkyl, Yj means hydroxy and Y2 means hydrogen or Rj means hydrogen, carbamyl or C1-C4-alkyl

og Yi og Y2 danner sammen en ekstra binding, hvorved R2 i et hvert tilfelle er karbamyl, eller and Y1 and Y2 together form an additional bond, whereby R2 in each case is carbamyl, or

c) omsetter en forbindelse av formelen c) reacts a compound of the formula

hvori Z står for reaktivt forestret hydroksy, med 1,2,3-triazol-4,5-dikarboksamid og, om ønsket, i den ifølge a), b) eller c) oppnådde forbindelsen med formel I acyleres den usubstituerte karbamyl gruppen R2 og eventuelt R! .' Overføringen av de nevnte gruppene R'2 og eventuelt R'^ til eventuelt C^-C^-alkylert karbamyl ifølge fremgangsmåtevariant a) foregår på vanlig måte ved ; ammonolyse, henholdsvis aminolyse (omsetning med ammoniakk eller et Ci-C4-alkylamin). in which Z stands for reactively esterified hydroxy, with 1,2,3-triazole-4,5-dicarboxamide and, if desired, in the compound of formula I obtained according to a), b) or c) the unsubstituted carbamyl group R2 is acylated and possibly R! .' The transfer of the aforementioned groups R'2 and optionally R'^ to optionally C^-C^-alkylated carbamyl according to method variant a) takes place in the usual way by; ammonolysis, respectively aminolysis (reaction with ammonia or a Ci-C4 alkylamine).

Ved ammonolysen, henholdsvis aminolysen arbeider man, om nødvendig, i nærvær av et kondensasjonsmiddel, fortrinnsvis i et inert oppløsningsmiddel. Kondensasjonsmidler er basiske kondensasjonsmidlér, fremfor alt ammoniakk, henholdsvis for aminolysen anvendte aminer i overskudd, med utgangspunkt i halogenidformen foreliggende karboksy, videre alkalimetall-hydroksyder eller -karbonater eller tertiære : organiske nitrogenbaser, som trilaverealkylaminer eller tertiære heteroaromatiske nitrogenbaser, som trietylamin eller pyridin. In the case of the ammonolysis, respectively the aminolysis, one works, if necessary, in the presence of a condensing agent, preferably in an inert solvent. Condensing agents are basic condensation agents, above all ammonia, respectively amines used for the aminolysis in excess, starting from the carboxy present in the halide form, further alkali metal hydroxides or carbonates or tertiary: organic nitrogen bases, such as trilower alkylamines or tertiary heteroaromatic nitrogen bases, such as triethylamine or pyridine.

En spesielt foretrukket utførelsesform av denne fremgangs-måtevarianten er kjennetegnet ved at man omsetter en forbindelse av formel I', hvori R'2 betyr en gruppe -COOR3 og R'l betyr hydrogen, Ci-C4~alkyl eller eventuelt en gruppe A particularly preferred embodiment of this method variant is characterized by reacting a compound of formula I', in which R'2 means a group -COOR3 and R'1 means hydrogen, C1-C4~alkyl or optionally a group

-COOR3, med et overskudd av ammoniakk eller et di-Ci~C4-alkylamin, og, om ønsket, i en ved fremgangsmåten oppnådd forbindelse, hvtiri R2 og eventuelt R^ betyr usubstituert karbamyl, Ci-C4-alkanoylierer R2 og eventuelt R^. Utgangsstoffene (I') kan, så fremt de ikke er kjente, fremstilles på vanlig måte, eksempelvis ved at man omsetter et azid av formelen med en forbindelse av formelen eksempelvis på analog måte som beskrevet under fremgangsmåtevariant b). Om nødvendig kan primært oppnådde estere henholdsvis nitriler med formelen I', (R'2 = forestret karboksy eller cyano) hydrolyseres til tilsvarende syre under basiske betingelser, f.eks. ved hjelp av vandig-alkoholisk natronlut, eller primært eller ved hydrolyse av tilsvarende estere eller nitriler oppnådde syrer med formelen (I, R'2 = Som utgangsstoffer med formel III for fremgangsmåtevariant b) kommer eksempelvis i betraktning forbindelser med formel Rj-CEC-R2 (Illa) og R1-C(=0)-CH2-R (IHb) (forbindelsen Illb er den tautomere formen av forbindelsen -COOR3, with an excess of ammonia or a di-Ci-C4-alkylamine, and, if desired, in a compound obtained by the process, where R2 and optionally R^ means unsubstituted carbamyl, Ci-C4-alkanoylates R2 and optionally R^ . The starting substances (I') can, as long as they are not known, be prepared in the usual way, for example by reacting an azide of the formula with a compound of the formula for example in an analogous way as described under method variant b). If necessary, primarily obtained esters or nitriles with the formula I', (R'2 = esterified carboxy or cyano) can be hydrolyzed to the corresponding acid under basic conditions, e.g. with the aid of aqueous-alcoholic caustic soda, or primarily or by hydrolysis of corresponding esters or nitriles obtained acids with the formula (I, R'2 = As starting materials with formula III for method variant b) for example compounds with the formula Rj-CEC-R2 are taken into consideration (Illa) and R1-C(=0)-CH2-R (IHb) (the compound Illb is the tautomeric form of the compound

(III; Yi = OH, (III; Yi = OH,

Y2 = H) ). Y2 = H) ).

Omsetningen av forbindelsene med II og III foregår på vanlig måte, fortrinnsvis i et inert oppløsningsmiddel, hvis nødvendig i nærvær av et kondensasjonsmiddel, og/eller ved forhøyet temperatur. Inerte oppløsningsmidler er eksempelvis aromatiske eller alifatiske hydrokarboner, som benzen eller toluen, eller eter som tertiærbutoksymetan, tetrahydrofuran og dioksan. The reaction of the compounds with II and III takes place in the usual way, preferably in an inert solvent, if necessary in the presence of a condensing agent, and/or at an elevated temperature. Inert solvents are, for example, aromatic or aliphatic hydrocarbons, such as benzene or toluene, or ethers such as tertiary butoxymethane, tetrahydrofuran and dioxane.

Foretrukkede utførelsesformer av denne fremgangsmåten er eksempelvis omsetningen av et azid med formel II med en forbindelse med formel Illa i benzen eller dioksan ved 60-120"C, fortrinnsvis koketemperatur. Preferred embodiments of this method are, for example, the reaction of an azide of formula II with a compound of formula Illa in benzene or dioxane at 60-120°C, preferably boiling temperature.

Utgangsstoffene med formel III og delvis med formel II er kjent. Nye utgangsstoffer med formel II kan fåes som analoge dannelsesmåter av de kjente, eksempelvis idet man omsetter en forbindelse med formel Ph-alk-Z IV, hvori Z betyr et reaksjonsdyktig, forestret hydroksy som halogen, f.eks. klor, brom eller jod, eller sulfonyloksy, som laverealkansulfonyloksy, eventuelt substituert benzensulfonyloksy, som metan-, etanbenzen-, p-toluen- eller p-brombenzensulfonyloksy eller fluorsulfonyloksy, med et alkalimetallåzid, f.eks. med natriumazid, eksempelvis dimetylsulfoksyd eller dimetylformamid, eller idet man bringer til reaksjon en alkohol med formel IV (Z = hydroksy) i nærvær av trifenylfosfin, og en azidodikarboksylsyreester, f.eks. azidokarboksylsyredietyles-ter med nitrogenhydrogensyre, eksempelvis i toluen. The starting substances with formula III and partly with formula II are known. New starting substances with formula II can be obtained as analogous formation methods of the known ones, for example by reacting a compound of formula Ph-alk-Z IV, in which Z means a reactive, esterified hydroxy such as halogen, e.g. chlorine, bromine or iodine, or sulfonyloxy, such as lower alkanesulfonyloxy, optionally substituted benzenesulfonyloxy, such as methane-, ethanebenzene, p-toluene- or p-bromobenzenesulfonyloxy or fluorosulfonyloxy, with an alkali metal azide, e.g. with sodium azide, for example dimethylsulfoxide or dimethylformamide, or by reacting an alcohol of formula IV (Z = hydroxy) in the presence of triphenylphosphine, and an azidodicarboxylic acid ester, e.g. azidocarboxylic acid diethyl ester with nitric acid, for example in toluene.

I utgangsstoffer IV ifølge fremgangsmåtevariant c) betyr reaksjonsdyktig forestret hydroksy eksempelvis halogen, f.eks. klor, brom eller jod, eller sulfonyloksy, som laverealkansulfonyloksy eller eventuelt substituert benzensulfonyloksy, som metan-, etan-, benzen-, p-toluen- eller p-brombenzensulfonyloksy eller fluorsulfonyloksy. In starting materials IV according to process variant c), reactive esterified hydroxy means, for example, halogen, e.g. chlorine, bromine or iodine, or sulfonyloxy, such as lower alkanesulfonyloxy or optionally substituted benzenesulfonyloxy, such as methane, ethane, benzene, p-toluene or p-bromobenzenesulfonyloxy or fluorosulfonyloxy.

Omsetningen foregår på vanlig måte, eksempelvis i nærvær av et basisk kondensasjonsmiddel, eller fordelaktig idet man anvender 1H-1,2,3-triazolkomponenter som salt, hvis nødvendig under oppvarming, fortrinnsvis i et oppløsnings- eller fortynningsmiddel. Basiske kondensasjonsmidler er eksempelvis med 1H-1,2,3-triazoikomponenten saltdannende basiske kondensasjonsmidler, som alkalimetallalkoholater, f.eks. natriummetanolat eller natriumetanolat, alkalimetall-, eller jordalkalimetallamider f.eks. natriumamid, eller litiumiso-propylamid. Overføringen av 1H-1,2,3-triazolkomponentene i et av deres salter gjennomføres fortrinnsvis på forhånd, f.eks. ved omsetning med en av de nevnte baser. Oppløsnings-midler er for gjennomføringen av omsetningen i nærvær av et alkoholat fortrinnsvis i tilsvarende alkoholer og ved gjennomføringen i nærvær av amider eksempelvis aprotiske, organiske oppløsningsmidler, som fosforsyrelaverealkylamider, f.eks. heksametylfosforsyretriamid, alkansyreamid, f.eks. dimetylformamid, eller dilaverealkylsulfoksyder, f.eks. dimetylsulfoksyd. Ifølge fremgangsmåten som biprodukt dannede isomere adskilles eventuelt fra de ønskede forbindelser med formel I. The reaction takes place in the usual way, for example in the presence of a basic condensing agent, or advantageously using 1H-1,2,3-triazole components as salt, if necessary under heating, preferably in a solvent or diluent. Basic condensing agents are, for example, salt-forming basic condensing agents with the 1H-1,2,3-triazo component, such as alkali metal alcoholates, e.g. sodium methanolate or sodium ethanolate, alkali metal or alkaline earth metal amides, e.g. sodium amide, or lithium isopropylamide. The transfer of the 1H-1,2,3-triazole components into one of their salts is preferably carried out in advance, e.g. by turnover with one of the aforementioned bases. Solvents for carrying out the reaction in the presence of an alcoholate are preferably corresponding alcohols and when carried out in the presence of amides, for example, aprotic, organic solvents, such as phosphoric acid lower alkyl amides, e.g. hexamethylphosphoric acid triamide, alkanoic acid amide, e.g. dimethylformamide, or dilave alkyl sulphoxides, e.g. dimethyl sulfoxide. According to the method, isomers formed as by-products are optionally separated from the desired compounds of formula I.

Utgangsstof f ene IV kan, hvis de ikke allerede er kjent, fremstilles på vanlig måte. Således får man forbindelser med formel IV f.eks., idet man reaksjonsdyktig forestrer en tilsvarende alkohol (IV, Z = hydroksy), f.eks. ved hjelp av tionylklorid, fosfortribromid, eller et sulfonylklorid. Starting substances f ene IV can, if they are not already known, be prepared in the usual way. Thus compounds of formula IV are obtained, for example, by esterifying a corresponding alcohol (IV, Z = hydroxy) in a reactive manner, e.g. using thionyl chloride, phosphorus tribromide, or a sulfonyl chloride.

Som omvandlingsreaksjoner for forbindelser oppnådd ved fremgangsmåten til andre forbindelser med formel (I) skal spesielt nevnes substitusjonsreaksjoner på N-usubstituerte eller N-monolaverealkylsubstituerte karbamylgrupper B£ og/eller R^ samt oppdelingen av isomerblandinger oppnådd ved fremgangsmåten. As conversion reactions for compounds obtained by the method to other compounds of formula (I) special mention must be made of substitution reactions on N-unsubstituted or N-monolower alkyl substituted carbamyl groups B£ and/or R^ as well as the division of isomer mixtures obtained by the method.

Følgelig kan man i forbindelser med formel (I) ved behandling med et Ci-C4-alkanoyleringsmiddel overføre N-usubstituert karbamyl til N-Ci-C4-alkanoylkarbamyl. Consequently, in compounds of formula (I) by treatment with a C1-C4-alkanoylating agent, N-unsubstituted carbamyl can be converted to N-C1-C4-alkanoylcarbamyl.

Ci-C4-alkanoyleringsmidler er eksempelvis Ci-C4-alkankarbok-sylsyreanhydrider som acetanhydrid eller det blandede anhydrid av maur- og eddiksyre, resp. Ci-C4-alkankarboksyl-syreklorider som acetylklorid. Omsetningen med disse foregår på vanlig måte hvis nødvendig i nærvær av en base, f.eks. av trietylamin eller pyridin, resp. i tilfelle av omsetningen med syreanhydrider i nærvær av mineralsyre, f.eks. av svovelsyre. Ci-C4-alkanoylating agents are, for example, Ci-C4-alkancarboxylic acid anhydrides such as acetic anhydride or the mixed anhydride of formic and acetic acid, resp. Ci-C4-alkanecarboxylic acid chlorides such as acetyl chloride. The turnover with these takes place in the usual way if necessary in the presence of a base, e.g. of triethylamine or pyridine, resp. in the case of the reaction with acid anhydrides in the presence of mineral acid, e.g. of sulfuric acid.

Oppdeling av isomerblandinger, som hvilke eksempelvis er å nevne blandinger av forbindelser med formel I, samt ifølge fremgangsmåten dannede isomerer av disse, foregår på vanlig måte. De kan eksempelvis adskilles på grunn av de forskjel-lige fysikalske egenskaper av komponentene ved vanlige fysikalske skillefremgangsmåter, f.eks. ved fraksjonert krystallisasjon, kromatografifremgangsmåter o.1. Separation of isomer mixtures, such as, for example, mixtures of compounds of formula I, as well as isomers thereof formed according to the method, takes place in the usual way. They can, for example, be separated due to the different physical properties of the components by normal physical separation methods, e.g. by fractional crystallisation, chromatography procedures etc.1.

Fremgangsmåter for fremstilling av nye utgangsstoffer, f.eks. med formel I', som spesielt ble utviklet for fremstilling av forbindelsene med formél I, spesielt ved utgangsstoffvalg som fører til de innledningsvis som foretrukket angitte forbindelser med formel I, samt deres anvendelse som mellomproduk-ter kan likeledes være en gjenstand for oppfinnelsen. Procedures for the production of new starting materials, e.g. with formula I', which was especially developed for the production of the compounds with formula I, especially by starting material selection that leads to the compounds with formula I indicated initially as preferred, as well as their use as intermediates can likewise be an object of the invention.

Oppfinnelsen skal forklares nærmere ved noen eksempler. The invention will be explained in more detail by some examples.

Eksempel 1 Example 1

73,5 g (0,25 mol) l-(o-fluorbenzyl)-lH-l,2,3-triazol-4 , 5-dikarboksylsyredimetylester oppløses i 1000 ml metanol. Deretter påpresser man i autoklav 250 g ammoniakk og hensetter i 24 timer ved 100°C. Deretter avkjøles, det utkrystalliserte produkt frasuges, vaskes med metanol, og omkrystalliseres fra dioksan/toluen. Man får l-(o-fluorben-zyl )-lH-l ,2 ,3-triazol-4 ,5-dikarboksamid av smp. 197-199-C. 73.5 g (0.25 mol) of 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylic acid dimethyl ester are dissolved in 1000 ml of methanol. 250 g of ammonia are then pressed into the autoclave and left for 24 hours at 100°C. It is then cooled, the crystallized product is sucked off, washed with methanol, and recrystallized from dioxane/toluene. One obtains 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 197-199-C.

Utgangsmaterialet kan f.eks. fremstilles på følgende måte: Til en til 90°C oppvarmet oppløsning av 41,5 g (0,275 mol) o-fluor-benzylazid i 50 ml toluen dryppes en oppløsning av 40 g (0,282 mol) acetylendikarboksylsyredimetylester i 500 ml toluen. Etter 5 ytterligere timer ved 90" C fjerner man toluen og frasuger etter avkjøling de utkrystalliserte stoffer. Etter omkrystalllsering fra en blanding av dietyleter og petroleter (1:1) får man således l-(o-fluorben-zyl )-lH-l,2,3-triazol-4,5-dikarboksylsyredimetylester av smp. 49-51'C. The starting material can e.g. is prepared in the following way: To a solution of 41.5 g (0.275 mol) of o-fluorobenzylazide in 50 ml of toluene heated to 90°C, a solution of 40 g (0.282 mol) of acetylene dicarboxylic acid dimethyl ester in 500 ml of toluene is added dropwise. After 5 additional hours at 90°C, the toluene is removed and, after cooling, the crystallized substances are filtered off with suction. After recrystallization from a mixture of diethyl ether and petroleum ether (1:1), l-(o-fluorobenzyl)-lH-l, 2,3-triazole-4,5-dicarboxylic acid dimethyl ester of mp 49-51°C.

Eksempel 2 Example 2

59 g (0,26 mol) l-(o-fluorbenzyl)-lH-l,2, 3-triazol-4-karboksylsyrer oppvarmes med 300 ml tlonylklorld i 1 time ved tilbakeløp. Deretter destillerer man overskytende tlonylklorld 1 vakuum, oppløser det gjenværende l-(o-fluorbenzyl)-lH-1,2,3-trlazol-4-karboksylsyreklorid i 500 ml toluen og drypper denne oppløsning ved 5-10°C til 500 ml av en konsentrert vandig ammoniakkoppløsning. Det utfelte produkt frasuges, vaskes med vann og omkrystal11seres fra etanol. Man får således l-(o-fluorbenzyl)-lH-l,2,3-triazol-4-karboksamid av smp. 220-222°C. 59 g (0.26 mol) of 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acids are heated with 300 ml of thlonyl chloride for 1 hour at reflux. Excess tlonyl chloride is then distilled off under vacuum, the remaining 1-(o-fluorobenzyl)-1H-1,2,3-trilazole-4-carboxylic acid chloride is dissolved in 500 ml of toluene and this solution is added dropwise at 5-10°C to 500 ml of a concentrated aqueous ammonia solution. The precipitated product is filtered off with suction, washed with water and recrystallized from ethanol. One thus obtains 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of m.p. 220-222°C.

Utgangsmaterialet kan f.eks. fremstilles på følgende måte: The starting material can e.g. produced in the following way:

En oppløsning av 50 g (0,33 mol) o-fluorbenzylazid, 23,1 g (0,33 mol) propinkarboksylsyre og 400 ml toluen omrøres 24 timer ved 70°C. Det utfelte produkt frasuges etter avkjøling til værelsestemperatur og vaskes først med toluen og deretter med dietyleter. Man får således l-(o-fluorbenzyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 151°C under spaltning. A solution of 50 g (0.33 mol) o-fluorobenzylazide, 23.1 g (0.33 mol) propynecarboxylic acid and 400 ml toluene is stirred for 24 hours at 70°C. The precipitated product is filtered off after cooling to room temperature and washed first with toluene and then with diethyl ether. One thus obtains 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 151°C during decomposition.

Eksempel 3 Example 3

Analogt som omtalt i eksempel 1, vil man når det gås ut fra 2,6-difluorbenzylazid og acetylendikarboksylsyredimetyleter over l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksyl-syredimetylester (smp. 62-65°C) få l-(2,6-difluorbenzyl)-lH-1,2,3-trlazol-4,5-dikarboksamid av smp. 203-2O5<*>C (fra metanol). ;Eksempel 4 ;Analogt eksempel 2 vil man, når det gås ut fra 2,6-dif luor-benzylazid over l-(2 ,6-difluorbenzyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 160-162°C under spaltning (fra acetonitril) få l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid av smp. 273-24CC (fra etanol). ;Eksempel 5 ;Analogt som omtalt 1 eksempel 1-4 kan man videre fremstille: l-(2,3-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid, l-(2,4-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid og 1- (2,5-difluorbenzyl)-lH-l,2,3-triazol-4-karboksamid. ;Eksempel 6 ;På analog måte som omtalt i eksempel 2, vil man av l-(6-klor-2- fluor-benzyl)-lH-l,2,3-triazol-4-karboksylsyre få l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4-karboksamid av smp. 274-276°C (fra iseddik). ;Utgangsmaterialet kan f.eks. fremstilles på følgende måte: En blanding av 98 g (0,678 mol) 6-klor-2-fluor-toluen, 91,5 g (0,678 mol) sulfurylklorid, og 0,2 g dibenzoylperoksyd omrøres 3 timer ved 100-110°C og destilleres deretter. Man får således 6-klor-2-fluor-benzylklorid, kokepunkt15 = 78-82° C. ;Til en suspensjon av 47 g (0,722 mol) natriumazid i 400 ml dimetylsulfoksyd drypper man ved 20-40°C 123 g (0,687 mol) 6-klor-2-fluor-benzylklorid. Etter 4 timers omrøring ved værelsestemperatur fortynnes med 1 liter isvann og ekstrahe-res med cykloheksan. Etter oppløsningsmidlets avdestillering destillers resten. Man får således 6-klor-2-fluor-benzyl-azid, kokepunkt15 <=> 99-100°C. ;27,5 g (0,15 mol) 6-klor-2-fluor-benzylazid og 10,5 g (0,15 mol) propinkarboksylsyre i 300 ml toluen, oppvarmes 3 timer ved 90°C. Etter avkjøling frasuges krystallene, og omkrystalliseres fra acetonitril. Man får således l-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 182°C under spaltning. ;Eksempel 7 ;På analog måte som omtalt i eksempel i vil man, når det gås ut fra 6-klor-2-fluor-benzylazid og acetylendikarboksylsyredimetylester over l-(6-klor-2-fluor-benzyl)-lH-l,2,3-trlazoi-4,5-dlkarboksylsyredlmetylester (smp. 88-90°C) få 1-(6-klor-2-fluor-benzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 214-216'C (fra iseddik). ;Eksempel 8 ;Analogt som omtalt i eksempel 1, vil man av 2,5-dif luorben-zylazid (kokepunkt15 = 82-84°C) over l-(2,5-difluor-benzyl)-1H-1,2,3-triazol-4,5-dikarboksylsyredimetylester få l-(2,5-difluorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 191-192'C (fra dioksan/toluen). ;Eksempel 9 ;På analog måte som i eksempel 1, vil man av 2,4-dif luorben-zylazid (kokepunkt15 = 80-83°C) over 1-(2,4-difluorbenzyl)-1H-1,2,3-triazol-4,5-dikarboksylsyredimetylester av smp. 75-76°C (fra cykloheksan) få l-(2,4-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 183-185°C (fra dioksan/toluen ). ;Eksempel 10 ;Analogt eksempel 1, vil man ved omsetning med dimetylamid få 1 -(2,6-di f luorbenzyl)-lH-l, 2 , 3-triazol-4,5-dikarboksyl-syre(N,N-dimetyl)amid av smp. 130-133°C (fra tertiærbutoksymetan). ;Eksempel 11 ;Analogt eksempel 1, vil man av 2,3-difluorbenzylazid og acetylendikarboksylsyredimetylester over l-(2,3-difluorben-zyl )-lH-l,2,3-triazol-4,5-dlkarboksylsyredlmetylester få 1-(2,3-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 183-185°C (fra eddikester/benzen). ;Eksempel 12 ;Analogt eksempel 2 vil man av l-(2,6-difluorbenzyl)-5-metyl-1H-1,2,3-triazol-4-karboksylsyre få l-(2,6-difluorbenzyl )-5-metyl-lH-l,2,3-trIazol-4-karboksamid av smp. 208-210'C (fra metanol). ;Utgangsmaterialet fremstillés som følger: ;Man oppløser 2,53 g (0,11 mol) natrium i 60 ml alkohol, tilsetter deretter en blanding av 16,9 g (0,1 mol) 2,6-difluorbenzylazid og 14,3 g (0,11 mol) aceteddikester i 60 ml alkohol og oppvarmer 18 timer til tilbakeløp. Etter tilsetning av 120 ml n-natronlut lar man det koke ytterligere 2 timer under tilbakeløp, fortynner med 200 ml vann og surgjør under avkjøling med saltsyre til pH 1. Det utfelte produkt frasuges, vaskes først med vann, deretter med eter og tørkes. Man får således l-(2,6-difluorbenzyl)-5-metyl-lH-1,2,3-triazol-4-karboksylsyre av smp. 166-167°C. ;Eksempel 13 ;Analogt eksempel 1 vil man av l-[l-(2,6-difluorfenyl)-etyl]-1H-1,2,3-triazol-4-karboksylsyreetylester få l-[l-(2,6-difluorfenyl)etyl]-1H-1,2,3-triazol-4-karboksamid av smp. 205-207°C (fra metanol ). ;Utgangsmaterialet fremstilles som følger: ;Ved reduksjon av 10,2 g (66 mmol) 2,6-difluoracetofenon med 2,5 g (65 mmol) 1itiumaluminiumhydrid i eter får man l-(2,6-difluorfenyl )etanol som fargeløs olje. ;Man oppløser 10 g (63 mmol) l-(2,6-dlfluorfenyl)etanol i 150 ml nitrogenhydrogensyreoppløsning (1,2 N i toluen), tilsetter 22,8 g (200 mmol) tr if luoreddiksyre, og lar det henstå I 24 timer ved værelsestemperatur. Etter fortynning med 300 ml heksan, vasker man først med vann, deretter med natriumbikar-bonatoppløsning syrefritt, tørker over natrlumsulfat og fjerner oppløsningsmidlet ved 40-50°C under nedsatt trykk. Resten oppløser man 1 100 ml heksan, filtrerer gjennom 50 g kiselgel og inndamper igjen. Man får således l-(2,6-difluorfenyl)-etylazid som fargeløs olje. ;6,5 g (35 mmol) l-( 2,6-dif luorfenyl )etylazid og 2,45 g (35 mmol) propinkarboksylsyre i 50 ml toluen oppvarmer man 24 timer ved 60-70°C. Etter avkjøling ekstraherer man med 100 ml n-natronlut, og får etter surgjøring med saltsyre 1-[1-(2,6-difluorfenyletyl)-lH-l,2,3-triazol-4-karboksylsyre av smp. 135-138°C under spaltning. ;7,1 g (26,6 mmol) l-[l-(2,6-difluorfenyl)etyl]-1H-1,2,3-triazol-4-karboksylsyre oppvarmes med 150 ml etanol og 1 ml svovelsyre i 10 timer under tilbakeløp. Etter opparbeidelse får man l-[l-(2,6-difluorfenyl)etyl]-1H-1,2,3-triazol-4-karboksylsyre-etylester av smp. 118-121°C. ;Eksempel 14 ;Analogt eksempel 1 vil man av l-{2-[2-(2,6-difluorfenyl)-propyl]>-lH-l,2,3-triazol-4-karboksylsyre få l-{2-[2-(2,6-difluorfenyl)propyl]}-lH-l,2,3-triazol-4-karboksamid av smp. 203-205°C (fra metanol). ;Utgangsmaterialet fremstilles som følger: ;Til 28 g (150 mmol) 2,6-dif luorbenzosyreetylester i 200 ml eter drypper man langsomt 120 ml av en 3-molar oppløsning av metylmagnesiumklorid i tetrahydrofuran. Etter 1 times tilbakeløp opparbeides med 105^-ig ammoniumkloridoppløsning får man 2-(2,6-difluorfenyl)-propan-2-ol (kokepunkt-^ = 74-76°C). 20,6 g (120 mmol) 2-(2,6-difluorfenyl)-propan-2-ol oppløses i 300 ml nitrogenhydrogensyreoppløsning (IN i benzen) og blandes med med 22,8 g (200 mmol) trifluoreddiksyre. Etter 24 timer ved værelsestemperatur fortynnes med heksan, vaskes med vann og deretter med natriumbikarbonatoppløsning syrefritt, tørkes med natriumsulfat, oppløsningsmidlet fordampes og resten destilleres. Man får således 2-(2,6-difluorfenyl )-2-azido-propan (kokepunkt-^ = 85-87°C). 10 g (51 mmol) 2-(2,6-difluorfenyl)-2-azido-propan omsettes med 3,6 g (51 mmol) propinkarboksylsyre i 100 ml toluen og opparbeides som omtalt i eksempel 13. Man får således l-{2-[2-( 2 , 6-dif luorfenyl )propyl]}-lH-l,2,3-triazol-4-karboksyl-syre av smp. 173° C under spaltning. ;Etter forestring av denne syre med 50 ml etanol og 0,5 ml kons. svovelsyre, får man l-{2-[2-(2,6-difluorfenyl)propyl])-1H-1,2,3-triazol-4-karboksylsyre som lysegul, tyktflytende olje, som kan anvendes uten ytterligere rensing for omsetningen med ammoniakk. ;Eksempel 15 ;Analogt eksempel 1 vil man, får det gås ut fra 2-(2,6-difluorfenyl)-2-azido-propan og acetylendikarboksylsyredimetylester over l-{2-[2-(2,6-difluorfenyl)propyl]}-lH-l,2,3-triazol-4,5-dikarboksylsyredimetylester (smp. 100-102°C) få l-{2-[2-(2,6-difluorfenyl)-propyl]>-lH-l ,2 , 3-1r iazol-4,5-dikarboksamid av smp. 177-178°C (fra eddikester/heksan). ;Eksempel 16 ;16,9 g (0,1 mol) 2,6-difluorbenzylazid og 8,3 g (0,1 mol) but-2-in-karboksamid oppvarmes i 20 ml dioksan i 16 timer ved 100°C. Etter dioksanets avdampning, adskilles den ønskede isomere ved søylekromatografi. Man får således l-(2,6-difluorbenzyl)-5-metyl-lH-l,2,3-triazol-4-karboksamid av smp. 208-210°C, (fra metanol ). ;Eksempel 17 ;2,81 g (10 mmol) l-(2,6-difluorfenyl)-lH-l,2,3-triazol-4,5-dikarboksamid, 20 ml acetanhydrid og 2 dråper svovelsyre, oppvarmes i 3 timer ved 80°C. Etter avkjøling utrører man med 100 ml vann i 1 time ved 20-25°C, frasuger det utfelte produkt og vasker med vann. Etter omkrystallisering fra 75 ml metanol får man således l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-di(N-acetyl)karboksamid av smp. 136-i38°C. ;Eksempel 18 ;På analog måte som i eksempel 17, får man også l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4-(N-acetyl)-karboksamid av smp. 205-207°C (fra dioksan-toluen). ;Eksempel 19 ;1,4 g (12,5 mmol) acetylendikarboksylsyrediamid oppløses ved 60<*>C i 10 ml dimetylsulfoksyd. Man tilsetter 1,69 g (10 mmol) 2,6-difluorbenzylazid og lar det omrøre i 16 timer ved 80°C. Analogous to that discussed in example 1, when starting from 2,6-difluorobenzyl azide and acetylenedicarboxylic acid dimethyl ether over 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylic acid dimethyl ester ( m.p. 62-65°C) give 1-(2,6-difluorobenzyl)-1H-1,2,3-trilazole-4,5-dicarboxamide of m.p. 203-2O5<*>C (from methanol). ;Example 4 ;Analogous to example 2, when starting from 2,6-difluorobenzylazide over 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 160-162°C with decomposition (from acetonitrile) obtain 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide of m.p. 273-24CC (from ethanol). ;Example 5 ;Analogously as described in examples 1-4, one can further prepare: 1-(2,3-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide, 1-(2,4-difluorobenzyl) -1H-1,2,3-triazole-4-carboxamide and 1-(2,5-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide. ;Example 6 ;In an analogous way as described in example 2, from l-(6-chloro-2-fluoro-benzyl)-lH-1,2,3-triazole-4-carboxylic acid, l-(6-chloro -2-fluoro-benzyl)-1H-1,2,3-triazole-4-carboxamide of m.p. 274-276°C (from glacial acetic acid). ;The starting material can e.g. is prepared as follows: A mixture of 98 g (0.678 mol) 6-chloro-2-fluorotoluene, 91.5 g (0.678 mol) sulfuryl chloride, and 0.2 g dibenzoyl peroxide is stirred for 3 hours at 100-110°C and is then distilled. 6-Chloro-2-fluoro-benzyl chloride is thus obtained, boiling point 15 = 78-82° C. To a suspension of 47 g (0.722 mol) of sodium azide in 400 ml of dimethylsulfoxide, 123 g (0.687 mol ) 6-chloro-2-fluoro-benzyl chloride. After stirring for 4 hours at room temperature, dilute with 1 liter of ice water and extract with cyclohexane. After the solvent has been distilled off, the residue is distilled. Thus, 6-chloro-2-fluoro-benzyl-azide is obtained, boiling point 15 <=> 99-100°C. 27.5 g (0.15 mol) of 6-chloro-2-fluoro-benzylazide and 10.5 g (0.15 mol) of propynecarboxylic acid in 300 ml of toluene are heated for 3 hours at 90°C. After cooling, the crystals are suctioned off and recrystallized from acetonitrile. One thus obtains 1-(6-chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 182°C during decomposition. ;Example 7 ;In an analogous way as discussed in example i, when starting from 6-chloro-2-fluoro-benzylazide and acetylenedicarboxylic acid dimethyl ester over l-(6-chloro-2-fluoro-benzyl)-lH-l, 2,3-trilazo-4,5-dlcarboxylic acid dlmethyl ester (m.p. 88-90°C) get 1-(6-chloro-2-fluoro-benzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 214-216'C (from glacial acetic acid). ;Example 8 ;Analogously as described in example 1, one wants from 2,5-difluorobenzylazide (boiling point 15 = 82-84°C) over 1-(2,5-difluoro-benzyl)-1H-1,2, 3-triazole-4,5-dicarboxylic acid dimethyl ester obtain 1-(2,5-difluorobenzyl )-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 191-192°C (from dioxane/toluene). ;Example 9 ;In an analogous way as in example 1, 2,4-difluorobenzylazide (boiling point 15 = 80-83°C) over 1-(2,4-difluorobenzyl)-1H-1,2,3 -triazole-4,5-dicarboxylic acid dimethyl ester of m.p. 75-76°C (from cyclohexane) obtain 1-(2,4-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 183-185°C (from dioxane/toluene). ;Example 10 ;Analogous to example 1, by reaction with dimethylamide, 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxylic acid (N,N-dimethyl )amide of m.p. 130-133°C (from tertiary butoxymethane). ;Example 11 ;Analogous to example 1, one will get 1-( 2,3-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 183-185°C (from acetic ester/benzene). ;Example 12 ;Analogous to example 2, from l-(2,6-difluorobenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid, l-(2,6-difluorobenzyl)-5- methyl-1H-1,2,3-triazole-4-carboxamide of m.p. 208-210°C (from methanol). ;The starting material is prepared as follows: ;One dissolves 2.53 g (0.11 mol) of sodium in 60 ml of alcohol, then adds a mixture of 16.9 g (0.1 mol) of 2,6-difluorobenzylazide and 14.3 g (0.11 mol) of acetic acid ester in 60 ml of alcohol and heat to reflux for 18 hours. After adding 120 ml of sodium hydroxide solution, it is allowed to boil for a further 2 hours under reflux, diluted with 200 ml of water and acidified while cooling with hydrochloric acid to pH 1. The precipitated product is filtered off with suction, washed first with water, then with ether and dried. One thus obtains 1-(2,6-difluorobenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxylic acid of m.p. 166-167°C. ;Example 13 ;Analogous to example 1, from l-[l-(2,6-difluorophenyl)-ethyl]-1H-1,2,3-triazole-4-carboxylic acid ethyl ester, l-[l-(2,6- difluorophenyl)ethyl]-1H-1,2,3-triazole-4-carboxamide of m.p. 205-207°C (from methanol). ;The starting material is prepared as follows: ;By reducing 10.2 g (66 mmol) of 2,6-difluoroacetophenone with 2.5 g (65 mmol) of lithium aluminum hydride in ether, 1-(2,6-difluorophenyl)ethanol is obtained as a colorless oil . ;One dissolves 10 g (63 mmol) of 1-(2,6-difluorophenyl)ethanol in 150 ml of nitric acid solution (1.2 N in toluene), adds 22.8 g (200 mmol) of trifluoroacetic acid, and allows it to stand 24 hours at room temperature. After dilution with 300 ml of hexane, it is first washed with water, then with acid-free sodium bicarbonate solution, dried over sodium sulfate and the solvent is removed at 40-50°C under reduced pressure. The residue is dissolved in 1,100 ml of hexane, filtered through 50 g of silica gel and evaporated again. Thus, 1-(2,6-difluorophenyl)-ethyl azide is obtained as a colorless oil. 6.5 g (35 mmol) of 1-(2,6-difluorophenyl)ethylazide and 2.45 g (35 mmol) of propynecarboxylic acid in 50 ml of toluene are heated for 24 hours at 60-70°C. After cooling, it is extracted with 100 ml of n-sodium hydroxide solution, and after acidification with hydrochloric acid, 1-[1-(2,6-difluorophenylethyl)-1H-1,2,3-triazole-4-carboxylic acid of m.p. 135-138°C during decomposition. ; 7.1 g (26.6 mmol) of 1-[1-(2,6-difluorophenyl)ethyl]-1H-1,2,3-triazole-4-carboxylic acid is heated with 150 ml of ethanol and 1 ml of sulfuric acid for 10 hours during reflux. After working up, 1-[1-(2,6-difluorophenyl)ethyl]-1H-1,2,3-triazole-4-carboxylic acid ethyl ester of m.p. 118-121°C. ;Example 14 ;Analogous to example 1, from l-{2-[2-(2,6-difluorophenyl)-propyl]>-lH-1,2,3-triazole-4-carboxylic acid, l-{2-[ 2-(2,6-difluorophenyl)propyl]}-1H-1,2,3-triazole-4-carboxamide of m.p. 203-205°C (from methanol). ;The starting material is prepared as follows: ;To 28 g (150 mmol) of 2,6-difluorobenzoic acid ethyl ester in 200 ml of ether, slowly add 120 ml of a 3-molar solution of methylmagnesium chloride in tetrahydrofuran. After refluxing for 1 hour, working up with 105^-ig ammonium chloride solution yields 2-(2,6-difluorophenyl)-propan-2-ol (boiling point-^ = 74-76°C). 20.6 g (120 mmol) of 2-(2,6-difluorophenyl)-propan-2-ol are dissolved in 300 ml of nitric acid solution (IN in benzene) and mixed with 22.8 g (200 mmol) of trifluoroacetic acid. After 24 hours at room temperature, dilute with hexane, wash with water and then with acid-free sodium bicarbonate solution, dry with sodium sulfate, evaporate the solvent and distill the residue. This gives 2-(2,6-difluorophenyl)-2-azidopropane (boiling point = 85-87°C). 10 g (51 mmol) of 2-(2,6-difluorophenyl)-2-azido-propane are reacted with 3.6 g (51 mmol) of propynecarboxylic acid in 100 ml of toluene and worked up as described in example 13. One thus obtains l-{ 2-[2-(2,6-difluorophenyl)propyl]}-1H-1,2,3-triazole-4-carboxylic acid of m.p. 173° C during decomposition. ;After esterification of this acid with 50 ml ethanol and 0.5 ml conc. sulfuric acid, 1-{2-[2-(2,6-difluorophenyl)propyl])-1H-1,2,3-triazole-4-carboxylic acid is obtained as a pale yellow, viscous oil, which can be used without further purification for the reaction with ammonia. ;Example 15 ;Analogous example 1 is desired, starting from 2-(2,6-difluorophenyl)-2-azido-propane and acetylenedicarboxylic acid dimethyl ester over l-{2-[2-(2,6-difluorophenyl)propyl] }-lH-l,2,3-triazole-4,5-dicarboxylic acid dimethyl ester (m.p. 100-102°C) get l-{2-[2-(2,6-difluorophenyl)-propyl]>-lH-l ,2 , 3-1r iazole-4,5-dicarboxamide of m.p. 177-178°C (from acetic acid/hexane). ;Example 16 ;16.9 g (0.1 mol) of 2,6-difluorobenzylazide and 8.3 g (0.1 mol) of but-2-yne carboxamide are heated in 20 ml of dioxane for 16 hours at 100°C. After the evaporation of the dioxane, the desired isomers are separated by column chromatography. One thus obtains 1-(2,6-difluorobenzyl)-5-methyl-1H-1,2,3-triazole-4-carboxamide of m.p. 208-210°C, (from methanol). ;Example 17 ;2.81 g (10 mmol) 1-(2,6-difluorophenyl)-1H-1,2,3-triazole-4,5-dicarboxamide, 20 ml of acetic anhydride and 2 drops of sulfuric acid, heated for 3 hours at 80°C. After cooling, stir with 100 ml of water for 1 hour at 20-25°C, filter off the precipitated product and wash with water. After recrystallization from 75 ml of methanol, 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-di(N-acetyl)carboxamide of m.p. 136-i38°C. ;Example 18 ;In an analogous way as in example 17, one also obtains 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-(N-acetyl)-carboxamide of m.p. 205-207°C (from dioxane-toluene). Example 19 1.4 g (12.5 mmol) of acetylene dicarboxylic acid diamide is dissolved at 60<*>C in 10 ml of dimethylsulfoxide. 1.69 g (10 mmol) of 2,6-difluorobenzylazide is added and it is allowed to stir for 16 hours at 80°C.

Man fortynner med 25 mi vann, frasuger, utrører med 50 ml vann og lar det omrøre 30 minutter ved 50-60° C, frasuger igjen, tørker og omkrystalliserer fra dioksan/etanol. Man får l-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid av smp. 203-205°C. It is diluted with 25 ml of water, aspirated, stirred with 50 ml of water and allowed to stir for 30 minutes at 50-60° C, aspirated again, dried and recrystallized from dioxane/ethanol. One obtains 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide of m.p. 203-205°C.

Claims (5)

1. Analogifremgangsmåte for fremstilling av terapeutisk anvendbare, fluorerte l-(ot-fenyllaverealkyl )-lH-l ,2 ,3- triazolforbindelser med formel hvori Ph betyr en i o-stilling med fluor, og eventuelt i tillegg med et ytterligere halogenatom, substituert fenylrest, alk betyr Cj-Cs-alkyliden, Rj_ betyr hydrogen, C-^- C^-alkyl eller en usubstituert eller med Ci-C4-alkanoyl eller Ci-C4-alkyl substituert karbamylgruppe og R2 står for en usubstituert eller med Ci-C4-alkanoyl eller C1-C4-alkyl substituert karbamylgruppe, karakterisert ved at man a) på kjent måte amiderer en forbindelse av formelen hvori R'i betyr hydrogen, Ci~G4-alkyl eller en gruppe, av formelen -C00R3 og R'2 betyr en gruppe -C00R3, hvorved R3 er Ci-Cfc-alkyl, eller R'^ er hydrogen eller C1-C4-alkyl og, R'2 er halogenkarbonyl, eller b) omsetter en forbindelse av formelen med en forbindelse av formelen som eventuelt kan foreligge i tautomer form, hvori Ri betyr Cj-C^alkyl, Y^ betyr hydroksy og Y2 betyr hydrogen eller R^ betyr hydrogen, karbamyl eller Ci~C4-alkyl og Yi og Y2 danner sammen en ekstra binding, hvorved R2 i et hvert tilfelle er karbamyl, eller c) omsetter en forbindelse av formelen hvori Z står for reaktivt forestret hydroksy, med 1,2,3-triazol-4,5-dikarboksåmid og, om ønsket, i den ifølge a), b) eller c) oppnådde forbindelsen med formel I acyleres den usubstituerte karbamylgruppen R2 og eventuelt Ri.1. Analogous process for the production of therapeutically useful, fluorinated 1-(o-phenyl lower alkyl)-1H-1,2,3- triazole compounds of formula in which Ph means an i o-position with fluorine, and optionally i addition with a further halogen atom, substituted phenyl radical, alk means C1-C5-alkylidene, Rj_ means hydrogen, C-1-C4-alkyl or an unsubstituted or C1-C4-alkanoyl or C1-C4-alkyl substituted carbamyl group and R2 stands for an unsubstituted or C1-C4-alkanoyl or C1-C4-alkyl substituted carbamyl group, characterized in that one a) amidates a compound of the formula in a known manner wherein R'i means hydrogen, C1-C4-alkyl or a group, of the formula -C00R3 and R'2 means a group -C00R3, whereby R3 is C1-C5-alkyl, or R'^ is hydrogen or C1-C4- alkyl and, R'2 is halocarbonyl, or b) reacts a compound of the formula with a compound of the formula which may possibly exist in tautomeric form, in which Ri means C1-C4 alkyl, Y^ means hydroxy and Y2 means hydrogen or R^ means hydrogen, carbamyl or C1-C4 alkyl and Y1 and Y2 together form an additional bond, whereby R2 in each case is carbamyl, or c) reacts a compound of the formula in which Z stands for reactively esterified hydroxy, with 1,2,3-triazole-4,5-dicarboxamide and, if desired, in the compound of formula I obtained according to a), b) or c), the unsubstituted carbamyl group R2 and optionally Ride. 2. Analogifremgangsmåte ifølge krav 1 for fremstilling av l-(o-fluorbenzyl )-lH-l,2,3-triazol-4,5-dikarboksamid, karakterisert ved at tilsvarende utgangsmaterialer anvendes.2. Analogous process according to claim 1 for the production of 1-(o-fluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, characterized in that corresponding starting materials are used. 3. Analogifremgangsmåte ifølge krav 1 for fremstilling av 1-( 2,6-di fl uorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid, karakterisert ved at tilsvarende utgangs-materialér anvendes.3. Analogous method according to claim 1 for the production of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, characterized in that corresponding starting materials are used. 4. Analogifremgangsmåte ifølge krav 1, for fremstilling av 1-(2,5-difluorbenzyl)-lH-l,2,3-triazol-4,5-dikarboksamid, karakterisert ved at tilsvarende utgangsmaterialer anvendes.4. Analogous method according to claim 1, for the production of 1-(2,5-difluorobenzyl)-1H-1,2,3-triazole-4,5-dicarboxamide, characterized in that corresponding starting materials are used. 5. Analogifremgangsmåte ifølge krav 1, for fremstilling av 1-(2,6-difluorbenzyl)-lH-l,2,3-triazol-4,5-di(N-acetyl)karboks-amid, karakterisert ved at tilsvarende utgangsmaterialer anvendes.5. Analogous method according to claim 1, for the production of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4,5-di(N-acetyl)carboxamide, characterized in that corresponding starting materials are used.
NO861486A 1985-04-18 1986-04-16 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS. NO164295C (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH166385 1985-04-18

Publications (3)

Publication Number Publication Date
NO861486L NO861486L (en) 1986-10-20
NO164295B true NO164295B (en) 1990-06-11
NO164295C NO164295C (en) 1990-09-19

Family

ID=4215715

Family Applications (1)

Application Number Title Priority Date Filing Date
NO861486A NO164295C (en) 1985-04-18 1986-04-16 ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS.

Country Status (22)

Country Link
EP (1) EP0199262B1 (en)
JP (1) JPS61243068A (en)
KR (1) KR900008810B1 (en)
AU (1) AU599024B2 (en)
CA (1) CA1272201A (en)
CY (1) CY1751A (en)
DD (1) DD245874A5 (en)
DE (1) DE3677626D1 (en)
DK (1) DK169720B1 (en)
ES (2) ES8800176A1 (en)
FI (1) FI93544C (en)
GR (1) GR861004B (en)
HK (1) HK1494A (en)
HU (1) HU203327B (en)
IE (1) IE58472B1 (en)
IL (1) IL78510A (en)
MX (1) MX9203628A (en)
NO (1) NO164295C (en)
NZ (1) NZ215871A (en)
PH (1) PH22568A (en)
PT (1) PT82400B (en)
ZA (1) ZA862873B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0151528B1 (en) * 1984-02-02 1990-07-04 Merck & Co. Inc. 5-(amino or substituted amino)-1,2,3-triazoles
AU2633897A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Solid phase and combinatorial synthesis of substituted 1,2,3-triazoles and of arrays of substituted 1,2,3-triazoles
KR100481137B1 (en) * 1996-07-11 2005-04-08 노파르티스 아게 Process for preparing 1-substituted 4-cyano-1,2,3-triazoles
TW403740B (en) 1997-06-10 2000-09-01 Novartis Ag Novel crystal modifications of the compound 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide
TW513301B (en) * 1999-03-01 2002-12-11 Novartis Ag Pharmaceutical composition for treatment of neuropathic pain and affective and attention disorders
WO2004106329A2 (en) * 2003-06-03 2004-12-09 Dr. Reddy's Laboratories Ltd. Novel antiinfective compounds and their pharmaceutical compositions
IT1393368B1 (en) * 2009-03-23 2012-04-20 Dipharma Francis Srl METHOD FOR THE PREPARATION OF RUFINAMIDE
IT1395736B1 (en) 2009-08-04 2012-10-19 Dipharma Francis Srl CRYSTALLINE FORMS OF RUFINAMIDE
US8884026B2 (en) * 2010-04-30 2014-11-11 Laboratorios Lesvi, S.L. Process for preparing rufinamide intermediate
ITMI20110718A1 (en) 2011-04-29 2012-10-30 Dipharma Francis Srl PROCEDURE FOR PURIFICATION OF RUFINAMIDE
US20150368211A1 (en) * 2013-01-31 2015-12-24 The Johns Hopkins University Rufinamide and derivatives and their use in modulating the gating process of human voltage-gated sodium channels
US9771335B2 (en) * 2015-07-31 2017-09-26 The Johns Hopkins University Derivatives of rufinamide and their use in inhibtion of the activation of human voltage-gated sodium channels
ES2902685T3 (en) 2015-12-11 2022-03-29 Univ Aarhus Rufinamide for use in the treatment of myotonia
WO2021099481A1 (en) 2019-11-20 2021-05-27 Medichem, S.A. Solid composition containing rufinamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1511195A (en) * 1976-10-18 1978-05-17 Ici America Inc Triazole derivatives
FI834666A (en) * 1982-12-23 1984-06-24 Ciba Geigy Ag FOERFARANDE FOER FRAMSTAELLNING AV NYA ARALKYLTRIAZOLFOERENINGAR.

Also Published As

Publication number Publication date
DK175686D0 (en) 1986-04-17
DD245874A5 (en) 1987-05-20
FI93544C (en) 1995-04-25
NZ215871A (en) 1989-01-27
ES8802501A1 (en) 1988-07-01
NO861486L (en) 1986-10-20
KR900008810B1 (en) 1990-11-30
PH22568A (en) 1988-10-17
ZA862873B (en) 1986-12-30
DE3677626D1 (en) 1991-04-04
MX9203628A (en) 1992-09-01
ES557641A0 (en) 1988-07-01
IE58472B1 (en) 1993-09-22
FI861573A0 (en) 1986-04-14
PT82400B (en) 1988-08-17
HU203327B (en) 1991-07-29
HUT40792A (en) 1987-02-27
IL78510A0 (en) 1986-08-31
NO164295C (en) 1990-09-19
GR861004B (en) 1986-08-12
KR860008152A (en) 1986-11-12
JPS61243068A (en) 1986-10-29
FI93544B (en) 1995-01-13
IE861015L (en) 1986-10-18
AU5631986A (en) 1986-10-23
ES8800176A1 (en) 1987-10-16
IL78510A (en) 1992-05-25
DK169720B1 (en) 1995-01-23
FI861573A (en) 1986-10-19
JPH0564949B2 (en) 1993-09-16
CY1751A (en) 1994-06-03
DK175686A (en) 1986-10-19
EP0199262A3 (en) 1987-08-26
CA1272201A (en) 1990-07-31
ES554024A0 (en) 1987-10-16
EP0199262A2 (en) 1986-10-29
HK1494A (en) 1994-01-14
AU599024B2 (en) 1990-07-12
PT82400A (en) 1986-05-01
EP0199262B1 (en) 1991-02-27

Similar Documents

Publication Publication Date Title
NO164295B (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE FLUORED BENZYLTRIAZOL COMPOUNDS.
US9096570B2 (en) Process for manufacturing substituted 3-pyridylmethyl ammonium bromides
US20110245506A1 (en) Process for Manufacturing Substituted 5-Methoxymethylpyridine-2,3-Dicarboxylic Acid Derivatives
JPH0468310B2 (en)
US4242261A (en) Production of methylene-cycloamines
EP1272480B1 (en) Method for the production of spirocyclic tetronic acid derivatives
US4692524A (en) Process for the preparation of pyrimidine derivatives
US4143227A (en) Process for substituted 5-benzyl-2,4-diamino-pyrimidines
NO834770L (en) PROCEDURE FOR THE PREPARATION OF NEW ARALKYLTRIAZOL COMPOUNDS
US5011927A (en) Preparation of 2-amino-4-fluoropyrimidine derivatives
US4990620A (en) Halogen substituted pyridylalkyl ketones
EP0708095A1 (en) Process for the preparation of alkoxytriazoles
US5663365A (en) Process for the preparation of pyrazolones
JPH0468309B2 (en)
SU523638A3 (en) Method for preparing imidazole derivatives or their salts
NO312027B1 (en) Process for the preparation of O- (3-amino-2-hydroxypropyl) hydroxymic acid halides
US20040199002A1 (en) Process for producing(2-nitrophenyl)acetonitrile derivative and intermediate therefor
FI77233C (en) FOERFARANDE FOER FRAMSTAELLNING AV 6-AMINONIKOTINSYRAS NIKOTINYLESTER.
US5623076A (en) Process for the preparation of chloromethylpyridines
JP2804559B2 (en) Method for producing 2-chloro-5-chloromethylpyridine
US4408044A (en) Preparation of 3,6-disubstituted 4-amino-1,2,4-triazin-5-ones
US5541332A (en) Chloropyridinium chlorides and process for their preparation
JPH06166666A (en) Hydrazone derivative and its production
US4115398A (en) Isoindoline derivatives and the acid addition salts thereof and process for the preparation of same
EP0298543B1 (en) Thiapentanamide derivatives